Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine

1d ago, source:

Dr. Kirkpatrick Leads the Company's Unique Response to Effectively Reduce Prescription Drug Overdose and Abuse ~ SAN DIEGO, ...

Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published

7d ago, source:

Webcast Replay Available on Ensysce's Investor Relations Website ~ SAN DIEGO, CA / ACCESSWIRE / April 19, 2024 / ...

Should You Invest in Coherus Biosciences Inc (CHRS) Now?

1d ago, source: newsheater

In conclusion, Coherus Biosciences Inc (CHRS) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important ...

Enveric Biosciences (ENVB) Price Target Decreased by 11.11% to 8.16

8d ago, source: Hosted on MSN

The average one-year price target for Enveric Biosciences (NasdaqCM:ENVB) has been revised to 8.16 / share.This is an decrease of 11.11% from the prior estimate of 9.18 dated March 28, 2024. The price ...

Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting

10d ago, source:

During a podium presentation, Jaya Biosciences’ scientific founder and science advisory board chair, Professor Mark Sands, reported on recently updated human genetic analyses suggesting that ...

Ensysce Biosciences, Inc.: Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine

1d ago, source:

Dr. Kirkpatrick Leads the Company's Unique Response to Effectively Reduce Prescription Drug Overdose and Abuse ~SAN DIEGO, CA / ACCESSWIRE / April 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (" ...